New ECMO device tested for safe transport of critically ill patients
NCT ID NCT07156669
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new medical device kit (Novalung ultimate kit with Xenios 2.0) in 20 adult patients with severe heart-lung failure who need ECMO life support. The goal is to see if the device safely and effectively maintains blood oxygen levels during hospital use and ground transport. The study is observational, meaning no new treatments are given—just careful monitoring of the device's performance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LUNG INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Krankenhaus Bethanien gGmbH
Solingen, 42699, Germany
-
University Hospital Aachen
Aachen, 52074, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could lung fluid proteins reveal a new way to track severe lung injury?
- Can a single antibody turn down the immune storm in ARDS?
- Blood test may forecast life-threatening clots or bleeds on ECMO
- Portable MRI could spot brain injury in children on life support
- New imaging technique may help ventilator settings for lung injury patients
- ECMO Patients' hidden infection risk under the microscope